Professional development of statisticians in the pharmaceutical sector: evolution over the past decade and into the future.
The adoption of The International Conference on Harmonization Tripartite Guideline: Statistical Principles for Clinical Trials (ICH-E9) has provided a foundation for the application of statistical principles in clinical research and raised awareness of the value of a statistical contribution to the wider pharmaceutical R&D process. In addition, over the past decade globalization of the pharmaceutical R&D process and the measures taken to address reduced productivity and spiralling costs have impacted on the roles and career opportunities for statisticians working in the pharmaceutical sector. This has enhanced the need for continuing professional development to equip statisticians with the skills to fully contribute to creating innovative solutions. In the future, key areas of focus are the establishment of professional standards for statistical work and increasing the collaboration between statisticians working in industry, regulatory agencies and academia. In addition, the diversity of roles and potential career paths for statisticians embarking on a career in the pharmaceutical sector emphasizes the importance of mentoring and coaching. For the more experienced statisticians, there are unprecedented opportunities to lead and innovate.
Lewis
Trevor
T
TLwise Consulting Limited, Cambridge, UK. trevorlewis@tiscali.co.uk
D004345:Drug Industry / Q000379:methods / Q000592:standards / Q000639:trends*; D005544:Forecasting; D017408:Guidelines as Topic / Q000592:standards; D006801:Humans; D024382:Professional Role; D012108:Research Personnel / Q000592:standards / Q000639:trends*; D013223:Statistics as Topic / Q000379:methods / Q000592:standards / Q000639:trends*